Ashland Navigates Market Headwinds: Life Sciences Shines Amidst Coatings Slump, Full-Year Outlook Adjusted
Specialty chemicals leader Ashland reports a mixed Q1 FY2026, with resilient performance in Life Sciences and Personal Care offsetting continued softness in coatings and construction. The company revises its full-year EBITDA guidance, citing operational delays at a key facility and weather-related disruptions.